Financhill
Sell
23

VIR Quote, Financials, Valuation and Earnings

Last price:
$6.12
Seasonality move :
40.15%
Day range:
$5.85 - $6.06
52-week range:
$4.16 - $14.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
49.00x
P/B ratio:
1.05x
Volume:
1.3M
Avg. volume:
1.9M
1-year change:
-18.39%
Market cap:
$833.4M
Revenue:
$74.2M
EPS (TTM):
-$3.62

Earnings Data

Next earnings date for VIR
Feb 25
2026
Most recent earnings per share
-$1.17
Missed by $0.31
(Nov 5/2025)
Consensus Estimate
-$0.86
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VIR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $19.9M -- -- -$0.51 --
11/05/2025 Q3 $2M $240K -$1.17 -$0.86 -$0.31
08/06/2025 Q2 $2.7M $1.2M -$0.80 -$0.72 -$0.08
05/07/2025 Q1 $8.6M $3M -$0.88 -$0.84 -$0.04
02/26/2025 Q4 $8.1M $12.4M -$0.76 -$0.87 $0.11
10/31/2024 Q3 $5.5M $2.4M -$1.56 -$1.08 -$0.48
08/01/2024 Q2 $7.5M $3.1M -$1.02 -$0.89 -$0.12
05/02/2024 Q1 $11.7M $56.4M -$0.48 -$1.05 $0.57
02/22/2024 Q4 $11.2M $16.8M -$0.86 -$1.00 $0.14
11/02/2023 Q3 $8.8M $2.6M -$1.22 -$1.19 -$0.03
08/03/2023 Q2 -- $3.8M -$1.45 -- --
05/04/2023 Q1 -- $63M -$1.06 -- --
02/23/2023 Q4 -- $49.4M -$0.76 -- --
11/03/2022 Q3 -- $374.6M $1.30 -- --
08/04/2022 Q2 -- -$40.6M -$0.58 -- --
05/05/2022 Q1 -- $1.2B $3.85 -- --
02/24/2022 Q4 -- $812.7M $3.92 -- --
11/04/2021 Q3 -- $103.6M $0.83 -- --
08/05/2021 Q2 -- $177.1M $0.46 -- --
05/06/2021 Q1 -- $2M -$1.32 -- --
02/25/2021 Q4 -- $1.7M -$0.83 -- --
11/10/2020 Q3 -- $1.9M -$0.67 -- --
08/11/2020 Q2 -- $67M -$0.27 -- --
05/12/2020 Q1 -- $5.7M -$0.71 -- --
03/26/2020 Q4 -- $980K -$0.59 -- --
11/19/2019 Q3 -- $1.4M -$0.44 -- --
06/30/2019 Q2 -- $2M -$0.31 -- --
03/31/2019 Q1 -- $3.7M -$0.26 -- --
12/31/2018 Q4 -- $3.1M -$0.24 -- --
09/30/2018 Q3 -- $2.9M -$0.31 -- --

Vir Biotechnology, Inc. Earnings Questions

  • How Much did Vir Biotechnology, Inc. Generate in Revenue Last Quarter?

    Vir Biotechnology, Inc. reported $240K worth of top line sales in its most recent quarter.

  • Did Vir Biotechnology, Inc. Beat Earnings Last Quarter?

    Vir Biotechnology, Inc. announced earnings per share of -$1.17 which represents a miss of analyst forecast a -$0.86 per share.

  • Is Vir Biotechnology, Inc. Profitable?

    Vir Biotechnology, Inc. reported -$2.7M that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for Vir Biotechnology, Inc. EPS Next Year?

    Vir Biotechnology, Inc.'s earnings are forecast to decrease from -$3.83 per share to -$3.92 per share next year representing a decrease of -12.43%.

  • When is Vir Biotechnology, Inc.'s Earnings Date?

    Vir Biotechnology, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock